Health Care Utilization and Cost Comparison Between Adherent Hypertension Patients Treated by Single Exforge HCT and Amlodipine/Valsartan/Hydrochlorothiazide Free Combination

This study investigated if Exforge HCT is associated with reduced health care utilization and costs during the 12 months follow up period in adult hypertensive (HTN) patients adherent to treatment.

Source: Value in Health - November 1, 2014 Category: Global & Universal Authors: W Chen, Z Wei, SH Ong, G Machnicki, K Kristijan Source Type: research